Lead sponsor
Vigonvita Life Sciences
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of November 5, 2026.
1
Trials led
1
Ongoing
200
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Not yet recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of Alzheimer's DiseaseMCI due to AD / mild AD dementiaPh 2Not yet recruiting200